Since FGFR2 pathway interacts with major signalling pathways, including BMP, WNT, Notch and Hedgehog, its aberrant activity is associated with developmental defects resulting in metabolic disorders, and cancer including lymphoma (reviewed in [34]). The gene discussed is FGFR2; the disease is cancer.